Investors & Biotech
The founders have a background as either MD or DVM and have spent more than 20 years in pharmaceutical industry, fulfilling a broad range of functions such as:
Medical director, Head of pre-clinical research, Head of in-licensing.
The group has evaluated more than 400 development projects within all major therapeutic areas and have participated in numerous due diligences and contract negotiations with biotech companies, including final in-licensing deals.
Evaluations have covered early as well as late-stage development projects.
Our main therapeutic area expertise include:
- Cardiovascular
- Hemostasis & thrombosis
- Pain
- Gastroenterology
- Metabolic diseases
- Dermatology
- Urology
We have close working relationships with additional experts and key opinion leaders in the clinical community, who are available on a project basis, as needed.
Project Identification/Assessment including:
- Description of disease and market
- Unmet medical need
- Medical utility / differentiation
- Product characterisation
- Competitive environment
- Development feasibility
- Target product profile
- Regulatory and IP assessment
- Risk assessment
- Recommendation
Project Strategy & Development including:
- Recommandations for strategic development optimisation
- Proposal for pre-clinical and clinical development plans
- Medical /scientific input to business plan
- Project management
- Ad hoc general management